Scrip
Avalon Pharmaceuticals struggles on
14 April 2009
Christopher Spillane
Please Login to read the full article.
14 April 2009
Christopher Spillane
christopher.spillane@informausa.com
The pressure is on
Avalon Pharmaceuticals to complete a pending merger with
Clinical Data after Avalon's auditors,
Ernst & Young, deemed the company a "going concern", expressing doubts about the firm's ability to continue. Avalon estimates that its current capital resources will be insufficient...
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
FEATURES
- Face to Face with Sandoz's "growth guy" Jeff George
- Recipharm sees opportunity to ride wave of CDMO consolidation
EVENTS
01 January 1970
London, UK
01 January 1970
San Diego, US
01 January 1970
Providence, Rhode Island, and San Francisco, California
JOB OF THE WEEK
Promote your vacancy here
